The Australian market has had a cautious start to the week, with most sectors in the red and only staples and energy showing strength. In such a fluctuating landscape, identifying stocks that combine solid financials with growth potential becomes crucial. Penny stocks, though often overlooked due to their size, can offer unique opportunities for those willing to explore smaller or newer companies with strong financial health. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.455 A$130.4M ★★★★★☆ EZZ Life Science Holdings (ASX:EZZ) A$2.47 A$116.52M ★★★★★★ IVE Group (ASX:IGL) A$2.77 A$427.08M ★★★★★☆ SHAPE Australia (ASX:SHA) A$4.18 A$344.2M ★★★★★★ West African Resources (ASX:WAF) A$2.90 A$3.31B ★★★★★★ LaserBond (ASX:LBL) A$0.515 A$60.59M ★★★★★★ Bravura Solutions (ASX:BVS) A$2.30 A$1.03B ★★★★★★ Praemium (ASX:PPS) A$0.745 A$356.27M ★★★★★★ MaxiPARTS (ASX:MXI) A$2.44 A$135.29M ★★★★★★ CTI Logistics (ASX:CLX) A$1.8625 A$150.01M ★★★★☆☆ Click here to see the full list of 450 stocks from our ASX Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Adore Beauty Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Adore Beauty Group Limited operates an integrated content, marketing, and e-commerce retail platform in Australia and New Zealand with a market cap of A$108.05 million. Operations: The company generates revenue of A$198.8 million from selling beauty and personal care products via its online platform. Market Cap: A$108.05M Adore Beauty Group Limited, with a market cap of A$108.05 million, reported full-year sales of A$198.8 million and net income of A$2.6 million for the fiscal year ending June 30, 2025. The company has shown consistent earnings growth, outperforming the Specialty Retail industry with a 19.5% increase over the past year and maintaining profitability over five years with an average annual growth rate of 6.8%. Despite experiencing a large one-off loss impacting recent results, Adore Beauty remains debt-free and trades below its estimated fair value while possessing strong short-term asset coverage for liabilities. Take a closer look at Adore Beauty Group's potential here in our financial health report. Assess Adore Beauty Group's future earnings estimates with our detailed growth reports.ASX:ABY Financial Position Analysis as at Aug 2025 Praemium Simply Wall St Financial Health Rating: ★★★★★★ Overview: Praemium Limited, with a market cap of A$356.27 million, offers advisors and wealth management solutions through a seamless digital platform in Australia and internationally. Operations: Praemium does not report specific revenue segments. Story Continues Market Cap: A$356.27M Praemium Limited, with a market cap of A$356.27 million, has demonstrated significant earnings growth of 55% over the past year, surpassing the Software industry average. The company reported full-year sales of A$103.04 million and net income of A$13.56 million for the fiscal year ending June 30, 2025, reflecting an improvement from the previous year. Praemium remains debt-free and trades at a good value compared to peers and its estimated fair value. Despite stable weekly volatility and experienced management and board teams, it faced a large one-off loss impacting recent financial results while maintaining strong short-term asset coverage for liabilities. Navigate through the intricacies of Praemium with our comprehensive balance sheet health report here. Examine Praemium's earnings growth report to understand how analysts expect it to perform.ASX:PPS Debt to Equity History and Analysis as at Aug 2025 SRG Global Simply Wall St Financial Health Rating: ★★★★★☆ Overview: SRG Global Limited operates as an engineering, mining, maintenance and construction contracting company in Australia and New Zealand, with a market cap of A$1.18 billion. Operations: The company's revenue is derived from Engineering and Construction, which contributes A$455.93 million, and Maintenance and Industrial Services, which accounts for A$867.38 million. Market Cap: A$1.18B SRG Global Limited, with a market cap of A$1.18 billion, has shown robust financial health and growth. The company reported full-year sales of A$1.32 billion, up from A$1.07 billion the previous year, and net income increased to A$47.48 million from A$34.44 million. Despite a low return on equity at 12.1%, SRG's earnings have grown significantly over five years by 50% annually on average, although recent growth decelerated to 37.9%. The company's debt is well-covered by operating cash flow and interest payments are comfortably managed by EBIT (44x coverage). SRG is strategically positioned for both organic and inorganic growth through potential acquisitions while maintaining a strong balance sheet that supports such endeavors. Get an in-depth perspective on SRG Global's performance by reading our balance sheet health report here. Explore SRG Global's analyst forecasts in our growth report.ASX:SRG Financial Position Analysis as at Aug 2025 Where To Now? Unlock more gems! Our ASX Penny Stocks screener has unearthed 447 more companies for you to explore.Click here to unveil our expertly curated list of 450 ASX Penny Stocks. Contemplating Other Strategies? The latest GPUs need a type of rare earth metal called Dysprosium and there are only 27 companies in the world exploring or producing it. Find the list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ABY ASX:PPS and ASX:SRG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Adore Beauty Group And 2 Other ASX Penny Stocks To Watch Closely
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...